Global Infectious Disease Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431718
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Abbvie, Inc.
  • Alere, Inc.
  • Allergan, Inc.
  • Baxter International Inc.
  • Bayer AG
  • MORE
Infectious Disease Treatment Market - Market Growth, Future Prospects, Competitive Analysis and Pipeline Analysis, 2017 - 2025, the global infectious disease treatment market was valued at US$ 153.55 Bn in 2016, and is expected to reach US$ 238.69 Bn by 2025 expanding at a CAGR of 4.88% from 2017 to 2025.

Market Insights

The infectious disease is transmitted from person to person, bites from insects and animals and by ingestion of contaminated food and water. It is further segmented into therapeutics (antibacterial drugs, antiviral drugs, antifungal drugs and anti-parasitic drugs) and application (AIDS, Hepatitis B, Hepatitis C, HPV, MRSA, CT/NG and Others). The antibacterial drugs are leading the therapeutic segment due to increasing prevalence of bacterial infection, technological advancement in antibacterial drug formulation, and rise in the number of antibiotic resistant bacteria. The antiviral drugs are gaining momentum due to the increasing prevalence of sexually transmitted diseases in developing and under developed countries, and developments in the field of safer antiviral drug formulations with fewer side effects. The human papillomavirus leads the application segment as the number of women suffering with this infection is around 290 million (1995-2005) according to the World Health Organization statistics. MRSA will be the fastest growing market in the application segment due to its rising prevalence, use of non-sterilized surgical devices, and combination of antibiotics are prescribed. The infectious disease treatment market comprises market players such as Pfizer, Inc., Abbvie, Inc., Alere, Inc., Bayer AG are few market leaders in global infectious disease treatment market and compete to augment their foothold in the market.

Key Market Movements:
  • High prevalence of infectious diseases
  • High public awareness and early disease diagnosis
  • Government and non-government organizations arranging awareness activities, camps and supporting reimbursement policies
  • Increasing investment in drug R&D resulting into promising pipeline
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Abbvie, Inc.
  • Alere, Inc.
  • Allergan, Inc.
  • Baxter International Inc.
  • Bayer AG
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Infectious Disease Treatment Market Portraiture
2.2 Global Infectious Disease Treatment Market, by Therapeutics, 2016 (US$ Mn)
2.3 Global Infectious Disease Treatment Market, by Application, 2016 (US$ Mn)
2.4 Global Infectious Disease Treatment Market, by Geography, 2016 (Value %)

Chapter 3 Global Infectious Disease Treatment Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising prevalence of infectious disease
3.2.2 Rising demand for personalized medication
3.3 Market Restraints
3.3.1 The emergence of drug resistant bacterial strains
3.4 Market Opportunities
3.4.1 Technological advancement in the anti-infective drug formulation to achieve more drug efficacy and fewer adverse effects
3.6 Attractive Investment Proposition
3.7 Market Competition Assessment: Infectious Disease Treatment, by Key Players

Chapter 4 Global Infectious Disease Treatment Market, By Therapeutics
4.1 Introduction
4.2 Antibacterial drugs
4.3 Antiviral drugs
4.4 Antifungal drugs
4.5 Antiparasitic drugs
4.6 Projected sales of Phase III drugs estimated till 2025 (US $ Mn)
4.6.1 Imipenem/Cilastatin + relebactum
4.6.2 Cadazolid
4.6.3 GS-9620 (TLR-7 Agonist)
4.6.4 Doravirine (MK-1439)
4.6.5 Others
4.7 Tabular representation of Phase II and I drugs

Chapter 5 Global Infectious Disease Treatment Market, By Application
5.1 Market Analysis
5.2 Acquired Immune Deficiency Syndrome (AIDS)
5.3 Hepatitis B
5.4 Hepatitis C
5.5 Human Papillomavirus
5.6 Hospital acquired Methicillin-resistant Staphylococcus aureus infection (MRSA)
5.7 Chlamydia trachomatis and Neisseria Gonorrhea (CT/NG)
5.8 Others

Chapter 6 Global Infectious Disease Treatment Market, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 Pfizer, Inc.
7.2 F.Hoffman-La Roche AG
7.3 Abbott Laboratories
7.4 Abbvie, Inc.
7.5 Merck & Company
7.6 Alere, Inc.
7.7 Allergan, Inc.
7.8 Bayer AG
7.9 Baxter International Inc.
7.10 Bristol-Myers Squibb Company
7.11 Actelion Pharmaceuticals Ltd.
7.12 Gilead Sciences, Inc.

List of Figures
Fig. 1 Global Infectious Disease Treatment Market: Research Methodology
Fig. 2 Global Infectious Disease Treatment Market, by Therapeutics, 2016 (US$ Mn)
Fig. 3 Global Infectious Disease Treatment Market, by Application, 2016 (US$ Mn)
Fig. 4 Global Infectious Disease Treatment Market, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition, by Geography, 2016
Fig. 6 Market Positioning of Key Infectious Disease Treatment Vendors, 2016
Fig. 7 Antibacterial Drugs Therapeutic Market, 2015 - 2025 (US$ Mn)
Fig. 8 Antiviral Drugs Therapeutic Market, 2015 - 2025 (US$ Mn)
Fig. 9 Antifungal Drugs Therapeutic Market, 2015 - 2025 (US$ Mn)
Fig. 10 Antiparasitic Drugs Therapeutic Market, 2015 - 2025 (US$ Mn)
Fig. 11 Pipeline Analysis: Global Imipenem/Cilastatin + relebactum Market, Upto 2025 (US$ Mn)
Fig. 12 Pipeline Analysis: Global Cadazolid Market, Upto 2025 (US$ Mn)
Fig. 13 Pipeline Analysis: Global GS-9620 (TLR-7 Agonist) Market, Upto 2025 (US$ Mn)
Fig. 14 Pipeline Analysis: Global Doravirine (MK-1439) Market, Upto 2025 (US$ Mn)
Fig. 15 Pipeline Analysis: Global Others Market, Upto 2025 (US$ Mn)
Fig. 16 Acquired Immune Deficiency Syndrome, Application Market, 2015 - 2025 (US$ Mn)
Fig. 17 Hepatitis B Application Market, 2015 - 2025 (US$ Mn)
Fig. 18 Hepatitis C Application Market, 2015 - 2025 (US$ Mn)
Fig. 19 Human Papillomavirus Application Market, 2015 - 2025 (US$ Mn)
Fig. 20 MRSA Application Market, 2015 - 2025 (US$ Mn)
Fig. 21 CT/NG Application Market, 2015 - 2025 (US$ Mn)
Fig. 22 Others Application Market, 2015 - 2025 (US$ Mn)
Fig. 23 Latin America Infectious Disease Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 24 Middle East and Africa Infectious Disease Treatment Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Infectious Disease Treatment Market, By Therapeutic, 2015-2025 (US$ Mn)
Table 2 Global Infectious Disease Treatment Market, By Application, 2015-2025 (US$ Mn)
Table 3 Global Infectious Disease Treatment Market, by Geography, 2015 - 2025 (US$ Mn)
Table 4 North America Global Infectious Disease Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 5 Europe Global Infectious Disease Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 6 Asia-Pacific Global Infectious Disease Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 7 Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 8 F.Hoffman-La Roche AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 9 Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 10 Abbive, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 11 Merck & Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 12 Alere, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 13 Allergan, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 14 Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 15 Baxter International Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 16 Bristol-Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 17 Actelion Pharmaceuticals, Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 18 Gilead Sciences, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Pfizer, Inc.
  • F.Hoffman-La Roche AG
  • Abbott Laboratories
  • Abbvie, Inc.
  • Merck & Company
  • Alere, Inc.
  • Allergan, Inc.
  • Bayer AG
  • Baxter International Inc.
  • Bristol-Myers Squibb Company
  • Actelion Pharmaceuticals Ltd.
  • Gilead Sc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll